Engineered Nanomedicine with Alendronic Acid Corona Improves Targeting to Osteosarcoma
Crossref DOI link: https://doi.org/10.1038/srep36707
Published Online: 2016-11-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nguyen, Tuyen Duong Thanh
Pitchaimani, Arunkumar
Aryal, Santosh
Text and Data Mining valid from 2016-11-08
Version of Record valid from 2016-11-08
Article History
Received: 21 July 2016
Accepted: 19 October 2016
First Online: 8 November 2016
Competing interests
: The authors declare no competing financial interests.